Olaparib plus paclitaxel plus carboplatin (P/C) followed by olaparib maintenance treatment in patients (pts) with platinum-sensitive recurrent serous ovarian cancer (PSR SOC): A randomized, open-label phase II study. Conference Paper uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Oza, Amit M
  • Cibula, David
  • Oaknin, Ana
  • Poole, Christopher John
  • Mathijssen, Ron HJ
  • Sonke, Gabe S
  • Colombo, Nicoletta
  • Spacek, Jiri
  • Vuylsteke, Peter
  • Hirte, Holger
  • Mahner, Sven
  • Plante, Marie
  • Schmalfeldt, Barbara
  • Mackay, Helen
  • Rowbottom, Jacqui
  • Tchakov, Ilian
  • Friedlander, Michael

publication date

  • May 20, 2012